{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:10:07Z","timestamp":1790187007090,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ejogrb.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,3,30]],"date-time":"2013-03-30T20:15:13Z","timestamp":1364674513000},"page":"248-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome"],"prefix":"10.1016","volume":"169","author":[{"given":"Silvia","family":"Garelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Masiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Furmaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decio","family":"Armanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Betterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2013.03.003_bib0005","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0015","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0025","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/humrep\/der088","article-title":"The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk","volume":"26","author":"Amato","year":"2011","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM199607113350206","article-title":"Chronic autoimmune thyroiditis","volume":"335","author":"Dayan","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0040","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJM200107263450406","article-title":"Subclinical hypothyroidism","volume":"345","author":"Cooper","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/eje.0.1500363","article-title":"High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome","volume":"150","author":"Janssen","year":"2004","journal-title":"European Journal of Endocrinology\/European Federation of Endocrine Societies"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0050","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00404-011-2040-5","article-title":"Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome","volume":"285","author":"Kachuei","year":"2012","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0055","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1530\/EJE-09-1012","article-title":"High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case\u2013control study","volume":"162","author":"Ganie","year":"2010","journal-title":"European Journal of Endocrinology\/European Federation of Endocrine Societies"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejim.2010.06.008","article-title":"Polycystic ovary syndrome and autoimmunity","volume":"21","author":"Petr\u00edkov\u00e1","year":"2010","journal-title":"European Journal of Internal Medicine"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/09513590701297658","article-title":"A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2","volume":"23","author":"Lee","year":"2007","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0070","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.fertnstert.2009.01.056","article-title":"Serologic markers of autoimmunity in women with polycystic ovary syndrome","volume":"93","author":"Hefler-Frischmuth","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-0378(01)00075-4","article-title":"Autoantibody studies of female patients with reproductive failure","volume":"51","author":"Reimand","year":"2001","journal-title":"Journal of Reproductive Immunology"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1530\/EJE-11-0840","article-title":"Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome","volume":"166","author":"Don\u00e0","year":"2012","journal-title":"European Journal of Endocrinology\/European Federation of Endocrine Societies"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0085","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/diacare.23.8.1177","article-title":"Autoimmunity against pancreatic islets and other tissues before and after interferon therapy in patients with hepatitis C virus chronic infection","volume":"23","author":"Betterle","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0090","first-page":"1440","article-title":"Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay","volume":"82","author":"Tanaka","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0095","first-page":"2977","article-title":"Analysis of autoantibody epitopes on steroid 21 hydroxylase using a panel of monoclonal antibodies","volume":"83","author":"Chen","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/thy.2010.1644","article-title":"Genetic susceptibility to autoimmune thyroid disease: past, present, and future","volume":"20","author":"Tomer","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0105","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1600-0463.2011.02779.x","article-title":"Association of polycystic ovarian syndrome with human leukocyte antigen polymorphism in Korean women","volume":"119","author":"Kim","year":"2011","journal-title":"APMIS"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-0897.2006.00369.x","article-title":"Studies on the human leukocyte antigens in patients with polycystic ovary syndrome in a Japanese population \u2013 possible susceptibility of HLA-A11 and -DRB1*0403 to patient population with polycystic ovary syndrome","volume":"55","author":"Kaibe","year":"2006","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0115","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"T4 and thyroid antibodies in the United States population (1998\u20131994 National Health Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0120","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.steroids.2012.02.010","article-title":"Polycystic ovary syndrome: implications of measurement of plasma aldosterone, renin activity and progesterone","volume":"77","author":"Armanini","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2010.08.002","article-title":"The role of low-grade inflammation in the polycystic ovary syndrome","volume":"335","author":"Repaci","year":"2011","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0130","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0135","first-page":"E388","article-title":"Characterization of aldosterone binding sites in circulating human mononuclear leukocytes","volume":"248","author":"Armanini","year":"1985","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.0802886","article-title":"Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity","volume":"184","author":"Herrada","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0145","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00296-011-2032-6","article-title":"Coexistence of primary aldosteronism and Hashimoto's thyroiditis","volume":"32","author":"Krysiak","year":"2012","journal-title":"Rheumatology International"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2006.10.013","article-title":"Treatment of polycystic ovary syndrome with spironolactone plus licorice","volume":"131","author":"Armanini","year":"2007","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2559.1991.tb00897.x","article-title":"Autoimmune oophoritis associated with polycystic ovaries","volume":"19","author":"Lonsdale","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0160","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0165","first-page":"107","article-title":"Premature ovarian failure and ovarian autoimmunity","volume":"18","author":"Hoek","year":"1997","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0170","doi-asserted-by":"crossref","first-page":"E1255","DOI":"10.1210\/jc.2011-0414","article-title":"Premature ovarian failure in patients with autoimmune Addison's disease: clinical, genetic and immunological evaluation","volume":"96","author":"Reato","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0175","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.fertnstert.2011.06.016","article-title":"Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea","volume":"96","author":"Li","year":"2011","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2013.03.003_bib0180","first-page":"3","article-title":"Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin","volume":"21","author":"Falbo","year":"2010","journal-title":"Journal of Ovarian Research"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211513001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211513001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:30:51Z","timestamp":1759555851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211513001164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0301211513001164"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.03.003","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}